Skip to content

Savitz Ryan Insider Trading -- Recent SEC Form 4 Transactions

Savitz Ryan (CIK 1992324) reported 39 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-12). Recent activity: Buy DNTH (29,276 shares), Sell DNTH (17,724 shares), Buy DNTH (40,430 shares), Buy DNTH (10,399 shares), Sell DNTH (300 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy29,276$523,455
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell17,724$1.6M
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy40,430$892,290
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy10,399$87,768
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell300$25,548
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell700$60,690
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell1,736$154,226
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy20,608$448,636
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell58,396$5.3M
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell2,064$189,042
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy1,301$28,323
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy1,260$27,808
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell2,561$230,849
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy1,744$37,967
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy1,300$28,691
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell3,044$274,051
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy1,339$29,150
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy16,385$361,617
2026-11-12Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell37,517$3.4M
2026-07-13Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell10,354$1.0M
2026-07-13Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell15,329$1.6M
2026-07-13Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell5,566$567,565
2026-07-13Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy31,249$680,291
2026-04-10Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOSell8,224$738,844
2026-04-10Dianthus Therapeutics, Inc. /DE/ (DNTH)EVP, CFO & CBOBuy8,224$147,045

Source: SEC Form 4 filings · as of 2026-11-12